710 Medtronic Parkway, NE
Medtronic, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world.
Founders: Earl Bakken and Palmer Hermundlie
CEO: Omar Ishrak
CFO: Karen Parkhill
CSO (Scientific): Richard Kuntz
Please click here for Medtronic job opportunities.
Tweets by Medtronic
1993 articles with Medtronic
AirXpanders, Inc., (ASX: AXP), announced that it has appointed a new President and CEO, Mr. Frank Grillo.
The medical device market was about $521.2 billion last year and is projected to hit $674.5 billion by 2022. Here’s a look at the top 10 medical device companies in the world this year.
New Study Investigates the Utility of Masimo SedLine® Patient State Index in Monitoring Anesthesia Depth of Patients with Healthy and Cirrhotic Livers
Masimo announced today the findings of an abstract presented at Euroanaesthesia 2018 Masimo Patient State Index (PSi) in monitoring the depth of anesthesia of two groups of patients.
Storytelling Training Leads Frontline Health Workers to Advocate at the Highest Levels of Governance
The firsthand perspectives of frontline health workers are becoming more influential at the highest levels of policymaking, including last week during the 71st World Health Assembly in Geneva, Switzerland.
New Medtronic Data Show Significant Blood Pressure Lowering Effect of Renal Denervation in Patients Taking Anti-Hypertensive Medication
Medtronic plc announced first-ever-data from the SPYRAL HTN-ON MED Study.
Medtronic IN.PACT(TM) Admiral(TM) Drug Coated Balloon Receives FDA Approval to Treat Long SFA Lesions
New Indication Expands DCB Treatment for Patients with SFA Lesions Up to 360mm
During a meeting with U.S. Food and Drug Administration Commissioner Scott Gottlieb earlier this week, government and healthcare officials in New Jersey highlighted the need to hasten the approval of new drugs and permanently eliminate the tax on medical devices.
ARCA biopharma announced positive headline results from its Phase IIb clinical trial of Gencaro, but investors aren't buying the positive spin.
Infiniti Research has announced the completion of their latest list of the top medical devices companies in the world.
The company’s study included 105 kids, ages 7 to 13.
The news release will include summary financial information for the company's third quarter of fiscal year 2018, which ended on Friday, January 26, 2018.
2/1/2018The company goes "above and beyond" with staggering 7% or greater dividend raises over 25 years.
Gu will serve on the company's Executive Committee and succeeds Chris Lee, who was named President of Medtronic's Asia Pacific (APAC) Region in December. This change is effective immediately.
The two companies will develop and commercialize the LungGPS Patient Management Platform.
The new data was presented at the Leipzig Interventional Course (LINC) in Leipzig, Germany.
Independently, QT Vascular will continue to develop and market its other products including a drug coated version of Chocolate PTA.
Medtronic Launches IDE Study to Evaluate the Abre Venous Self-Expanding Stent System in Patients With Deep Venous Disease
The multi-center, single arm study intends to enroll 200 subjects with deep venous disease from up to 35 sites throughout the U.S. and Europe.
Medtronic Launches ENCHANT Study to Evaluate ChEVAR Parallel Graft Technique With the Endurant II/IIs Stent Graft System
The first enrollment at St. Franziskus Hospital in Munster, Germany, was led by Professor Giovanni B. Torsello, M.D., chief of Vascular Surgery and principal investigator for the ENCHANT study.
The medtech titan logged a series of legal wins this week.
The Riptide Aspiration System is designed to retrieve thrombus (or blood clot) through the Arc Catheter and restore blood flow in patients experiencing blockage of an artery in the brain.